BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Surgical Robot Maker Medrobotics Raises $8 Million


8/14/2012 8:05:56 AM

Boston Business Journal by Patricia Resende, MHT

A maker of surgical robotic technologies, Medrobotics Corp., has secured a Series D round of funding, federal documents show.

The $8M round of equity, warrants and other options is part of a $20 million offering. A total of 18 investors have invested in the offering, according to the Aug. 10 filing. Listed on the filing are executives Samuel Starface, president and CEO; Kevin Gilmartin, vice president of research and development; Shawn Wery, vice president of clinical-regulatory affairs; Mark Peters, CFO; and David Smith, secretary. Listed as directors in the filing are Richard Petersen Jr., president of Petersen Jr. Enterprises; John Petersen, former president at Erie Insurance Group; Thomas Dugan, a retired cardiologist; Robert Beck, senior member of Beck, Mack & Oliver; and James Jordan, chief investment officer, Pittsburgh Life Sciences Greenhouses.

In December, Medrobotics secured $6.4 million from investors and in November, it closed a $11.7 million “Series C” funding from its current shareholders, a number of angel investors and The Pittsburgh Life Sciences Greenhouse. Its $11.6 million Series A round came in August 2009 and was led by Eagle Ventures.

Founded in 2005, the Raynham-based company is a developer of robotic surgical products such as cardioARM, a robotic probe controlled remotely and designed to enable surgeries with minimal or no incisions. Medrobotics’ robotic probe moves within any 3-D space without needing any other structural support, according to the company.

The company was originally co-founded in Pittsburgh as Innovention Technologies LLC. by Howie Choset, PhD, an associate professor of robotics at Carnegie Mellon University, Dr. Marco Zenati, a cardiothoracic surgeon and Visiting Professor of Surgery at Harvard Medical School, and Alon Wolf, associate professor at Technion University in Israel. It then moved its headquarters to Newport, RI and operated as Cardiorobotics before settling in Raynham under the name Medrobotics Corp. Two of the three co-founders, Choset and Zenati, are still involved in Medrobotics’ product development.



Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES